MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1457 blog entries.

New Research Study: Family-Based Intervention to Reduce Anxiety in 2- to 3-Year-Old Children  

Anxiety disorders affect as many as 30% of children and adolescents, and the children of parents with an anxiety disorder have a higher risk of developing an anxiety disorder than the children of parents [...]

By |2021-05-06T15:12:00-04:00November 18th, 2020|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on New Research Study: Family-Based Intervention to Reduce Anxiety in 2- to 3-Year-Old Children  

Weekly Roundup for NOVEMBER 13, 2020: Recent Publications in Women’s Mental Health

Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and [...]

By |2020-11-14T18:21:10-04:00November 14th, 2020|Weekly Roundup|Comments Off on Weekly Roundup for NOVEMBER 13, 2020: Recent Publications in Women’s Mental Health

How Do Race and Ethnicity Impact Access and Utilization of Perinatal Mental Health Services?

Growing attention is being given to the public health dimensions of perinatal mood and anxiety disorders (PMADs). Previously, we have reviewed studies looking at the prevalence of screening for PMADs and disparities therein and [...]

By |2020-11-12T11:35:50-04:00November 10th, 2020|Anxiety Disorders, Psychiatric Disorders During Pregnancy|Comments Off on How Do Race and Ethnicity Impact Access and Utilization of Perinatal Mental Health Services?

Modafinil and Armodafinil During Pregnancy: Data to Suggest Increased Risk of Malformations

As soon as we published this article on the use of modafinil during pregnancy, another study was published which included data on the reproductive safety of modafinil and armodafinil from the US Provigil/Nuvigil Pregnancy [...]

By |2022-01-20T18:11:36-04:00November 4th, 2020|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Modafinil and Armodafinil During Pregnancy: Data to Suggest Increased Risk of Malformations

Study Supporting the Reproductive Safety of Gabapentin During Pregnancy

Gabapentin (Neurontin) is now used in a wide variety of clinical settings — for the treatment of epilepsy, pain management, restless leg syndrome, anxiety, and sleep disturbance.  However, there is relatively little information regarding [...]

By |2020-11-17T15:58:03-04:00October 28th, 2020|Alternative & Complementary, Anti-Anxiety Medications, Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Study Supporting the Reproductive Safety of Gabapentin During Pregnancy

Weekly Roundup for OCTOBER 23, 2020: Recent Publications in Women’s Mental Health

Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and [...]

By |2020-10-28T17:47:38-04:00October 25th, 2020|Weekly Roundup|Comments Off on Weekly Roundup for OCTOBER 23, 2020: Recent Publications in Women’s Mental Health

New (But Still Not Enough) Data on Modafinil and Pregnancy

Modafinil (brand name Provigil) is a wake-promoting agent which is used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea.  It is also used in other settings, often in [...]

By |2020-11-17T16:01:54-04:00October 20th, 2020|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on New (But Still Not Enough) Data on Modafinil and Pregnancy
Go to Top